Sify.com » Topics » Cadila
Cadila News
Zydus Cadila joins the billion dollar league
Ahmedabad based pharma major Zydus Cadila has ended the financial year 2010-11 with revenues touching $1 billion(over Rs 4500 crore) mark. Chairman and managing director of Zydus Cadila, Pankaj Patel said,"When we began our journey to the billion in 2006-07, we knew it would be a big leap forward. This has been the result of an all-round effort in terms of strengthening existing businesses, building
Ahmedabad based pharma major Zydus Cadila has ended the financial year 2010-11 with revenues touching $1 billion(over Rs 4500 crore) mark. Chairman and managing director of Zydus Cadila, Pankaj Patel said,"When we began our journey to the billion in 2006-07, we knew it would be a big leap forward. This has been the result of an all-round effort in terms of strengthening existing businesses, building
Cadila Healthcare: Marginal benefits from Taxotere
Cadila will supply the oncology drug to joint venture partner Hospira.
Cadila will supply the oncology drug to joint venture partner Hospira.
Cadila Pharma spreads wings to Rwanda
Ahmedabad-based Cadila Pharmaceuticals Ltd is all set to step into Rwandan soil. CSM Global Pharma, a joint venture between Cadila Pharma and US-based Holtzman Group will invest $65 million to set
France woos India Inc for Pharma, IT sectors
As a testimony to the sustained recovery in the global economic situation, France has opened its arm for the India Inc to expand their presence by setting up units on the European soil.
As a testimony to the sustained recovery in the global economic situation, France has opened its arm for the India Inc to expand their presence by setting up units on the European soil.
Zydus, Bayer Healthcare enter 50:50 venture
Ahmedabad-based Zydus Cadila and Germany’s Bayer Healthcare have signed an agreement to set up a 50:50 joint venture (JV) company Bayer Zydus Pharma to market pharmaceutical products in India.
Ahmedabad-based Zydus Cadila and Germany’s Bayer Healthcare have signed an agreement to set up a 50:50 joint venture (JV) company Bayer Zydus Pharma to market pharmaceutical products in India.
Product launches, global markets drive growth
Cadila Healthcare, which derives an equal proportion of revenues from domestic and global markets, continued its robust performance in the third quarter ended December. On a year-on-year basis,
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre.
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise